Log In
Print
BCIQ
Print
Print this Print this
 

SAPPHIRE II eye test

  Manage Alerts
Collapse Summary General Information
Company Cognoptix Inc.
DescriptionLigand/contrast agent combined with a software-controlled optical instrument that allows for the non-invasive detection of a fluorescent signature of beta amyloid in the supranuclear region of the lens of the eye
Molecular Target Beta amyloid
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationNeurology, Diagnostic
Indication DetailsEarly detection of Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today